These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 33096664)
1. Ligand-Based Pharmacophore Modeling, Molecular Docking, and Molecular Dynamic Studies of Dual Tyrosine Kinase Inhibitor of EGFR and VEGFR2. Sangande F; Julianti E; Tjahjono DH Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096664 [TBL] [Abstract][Full Text] [Related]
2. Structural and molecular insights from dual inhibitors of EGFR and VEGFR2 as a strategy to improve the efficacy of cancer therapy. Budipramana K; Sangande F Chem Biol Drug Des; 2024 May; 103(5):e14534. PubMed ID: 38697951 [TBL] [Abstract][Full Text] [Related]
3. Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies. Bilal MS; Ejaz SA; Zargar S; Akhtar N; Wani TA; Riaz N; Aborode AT; Siddique F; Altwaijry N; Alkahtani HM; Umar HI Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358960 [TBL] [Abstract][Full Text] [Related]
4. Molecular dynamics guided insight, binding free energy calculations and pharmacophore-based virtual screening for the identification of potential VEGFR2 inhibitors. Rathi E; Kumar A; Kini SG J Recept Signal Transduct Res; 2019; 39(5-6):415-433. PubMed ID: 31755336 [TBL] [Abstract][Full Text] [Related]
5. Identification of potentially high drug-like VEGFR2/c-Met dual-target type II kinase inhibitors with symmetric skeletons based on structural screening. Xie J; Zhang X; Meng D; Li Y; Deng P J Biomol Struct Dyn; 2024; 42(3):1249-1267. PubMed ID: 37042992 [TBL] [Abstract][Full Text] [Related]
7. Identification of Novel EGFR Inhibitors for the Targeted Therapy of Colorectal Cancer Using Pharmacophore Modelling, Docking, Molecular Dynamic Simulation and Biological Activity Prediction. Krishnan K A; Valavi SG; Joy A Anticancer Agents Med Chem; 2024; 24(4):263-279. PubMed ID: 38173208 [TBL] [Abstract][Full Text] [Related]
8. Recent advances in structure-based drug design and virtual screening of VEGFR tyrosine kinase inhibitors. Hoi PM; Li S; Vong CT; Tseng HH; Kwan YW; Lee SM Methods; 2015 Jan; 71():85-91. PubMed ID: 25239735 [TBL] [Abstract][Full Text] [Related]
9. Computational Evaluation and In Vitro Validation of New Epidermal Growth Factor Receptor Inhibitors. Gómez-Ganau S; Castillo J; Cervantes A; de Julián-Ortiz JV; Gozalbes R Curr Top Med Chem; 2020; 20(18):1628-1639. PubMed ID: 32493189 [TBL] [Abstract][Full Text] [Related]
11. Identification of tyrosine kinase inhibitors from Panax bipinnatifidus and Panax pseudoginseng for RTK-HER2 and VEGFR2 receptors, by in silico approach. Paul D; Mahanta S; Tag H; Das SK; Das Gupta D; Tanti B; Ananthan R; Das R; Jambhulkar S; Hui PK Mol Divers; 2022 Aug; 26(4):1933-1955. PubMed ID: 34554395 [TBL] [Abstract][Full Text] [Related]
17. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease. Iqbal S; Anantha Krishnan D; Gunasekaran K J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053 [TBL] [Abstract][Full Text] [Related]
18. A preclinical evaluation of SKLB261, a multikinase inhibitor of EGFR/Src/VEGFR2, as a therapeutic agent against pancreatic cancer. Pan Y; Zheng M; Zhong L; Yang J; Zhou S; Qin Y; Xiang R; Chen Y; Yang SY Mol Cancer Ther; 2015 Feb; 14(2):407-18. PubMed ID: 25519702 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel 4-anilinoquinazoline derivatives as hypoxia-selective EGFR and VEGFR-2 dual inhibitors. Wei H; Duan Y; Gou W; Cui J; Ning H; Li D; Qin Y; Liu Q; Li Y Eur J Med Chem; 2019 Nov; 181():111552. PubMed ID: 31387063 [TBL] [Abstract][Full Text] [Related]
20. Structure and activity relationship analysis of xanthones from mangosteen: Identifying garcinone E as a potent dual EGFR and VEGFR2 inhibitor. Li J; Nie X; Panthakarn Rangsinth ; Wu X; Zheng C; Cheng Y; Shiu PH; Li R; Lee SM; Fu C; Zhang J; Leung GP Phytomedicine; 2024 Jan; 122():155140. PubMed ID: 37939410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]